glp 1 agonist schizophrenia GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 receptor agonists show promise

Your BMR is the amount of energy that your body uses each day simply to maintain itself

REWIND (2019) Dulaglutide extended benefit into a broader, lower-risk population challenging the idea this was only for those with established disease

Consultations are all handled via secure asynchronous messaging or video calls

We want to lose fat, we dont want to lose muscle, and we really dont want to lose bone

Besides diabetes, GLP - 1RAs have exhibited gut microbiota - modifying effects in other metabolic disorders, especially some bacteria associated with glycolipid metabolism and intestinal inflammation (Liu et al., 2020b

in people with diabetes) are ongoing to assess the efficacy and durability of weight loss with 3.6 and 6 mg doses over 76 weeks (clinical trial numbers NCT06066515 and NCT06066528)